Matches in Nanopublications for { ?s ?p "[Together, our findings suggest that selectively targeting tumor-elicited myeloid cells or versican represents a potential therapeutic strategy for combating metastatic disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- assertion description "[Together, our findings suggest that selectively targeting tumor-elicited myeloid cells or versican represents a potential therapeutic strategy for combating metastatic disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP701423.RA9QLJdVo5aMaLFdWo1m_YuIXB8K044jCy32gB6KI2qdk130_assertion description "[Together, our findings suggest that selectively targeting tumor-elicited myeloid cells or versican represents a potential therapeutic strategy for combating metastatic disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP701423.RA9QLJdVo5aMaLFdWo1m_YuIXB8K044jCy32gB6KI2qdk130_provenance.
- NP332859.RAf2IfYGitUSFHxZ7ozO5nSsu0qv_9u_4nugGbbhtLTCU130_assertion description "[Together, our findings suggest that selectively targeting tumor-elicited myeloid cells or versican represents a potential therapeutic strategy for combating metastatic disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP332859.RAf2IfYGitUSFHxZ7ozO5nSsu0qv_9u_4nugGbbhtLTCU130_provenance.
- NP332985.RAPHeB-JQ1Ck39f797tpLX5Hj_MOyXQ1M9f1QzMq30nKQ130_assertion description "[Together, our findings suggest that selectively targeting tumor-elicited myeloid cells or versican represents a potential therapeutic strategy for combating metastatic disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP332985.RAPHeB-JQ1Ck39f797tpLX5Hj_MOyXQ1M9f1QzMq30nKQ130_provenance.
- NP956463.RALrI1o5YZoVG1_7h-nhXNdzbaRxMkMOIrIghg_q4oxKI130_assertion description "[Together, our findings suggest that selectively targeting tumor-elicited myeloid cells or versican represents a potential therapeutic strategy for combating metastatic disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP956463.RALrI1o5YZoVG1_7h-nhXNdzbaRxMkMOIrIghg_q4oxKI130_provenance.